- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06230341
Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study (EVIDENS-Prim)
In France, improving the practice of health professionals working in coordinated primary care teams (health centres called Maisons de Santé Pluriprofessionnelles - MSPs) could be facilitated by a learning system consisting of (i) a risk management support programme and (ii) the provision of a comprehensive online system combining training, reporting and support for the analysis and management of patient safety incidents (PSIs).
EVIDENS-Prim is a multi-method, multi-centre, prospective study. It aims to describe the PSIs that occur in MSPs, using an international classification system, and to describe the ways in which professionals have adopted a global approach to PSIs management, from PSI reporting to feedback.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This method combines:
- (i) A sequential study of PSIs analysis. The sequential study will take place in three stages (coder training, collection of PSIs data via the web platform, PSIs coding).
Each PSIs reported by professionals during the implementation of the risk management support programme will be coded using the PISA multi-axial classification system (based on the WHO's International Classification for Patient Safety in Primary Care). These codes will be used to describe PSIs in coordinated practice.
- (ii) An implementation study of the learning system. The learning system is described in the intervention section. During the implementation study, two types of data collection (quantitative and qualitative) will be mobilised at the end of the support to the QualiREL Santé Regional Support Structure.
The main objective of the study is:
- To Describe PSIs occurring in MSPs as part of the coordinated exercise and over an 18-month period, according to the 4 coding frameworks of the PISA classification: (i) types of events (main and contributing), (ii) contributing factors, (iii) outcomes of PSIs, (iv) severity of harm.
The secondary objectives, linked to the evaluation of the implementation of the learning system, are
- To examine the acceptance of the learning system by the teams,
- To describe the effective use of the web platform by professionals,
- To describe the MSP's ownership of the risk management support programme.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jean-Baptiste Amélineau, MD
- Phone Number: 02 40 41 28 28
- Email: jean-baptiste.amelineau@univ-nantes.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Characteristics of the MSPs included in the study:
- Located in the Pays de la Loire region;
- Having a contract with a health insurance (specifications and financing defined nationally) for at least 1 year;
- Agreeing to take part in the project;
- Having a quality representative or committing to appoint one when they join the project.
Characteristics of professionals working in MSPs included:
- All independent health professionals involved in the MSP: general practitioners and, depending on the MSP, nurses, pharmacists, podiatrists, physiotherapists, midwives, speech therapists, dentists, occupational therapists, psychomotor therapists, etc,)
- All professionals involved in MSP outside the health sector: (coordinators, medical assistants, independent psychologists, etc.),
- agree to take part in the project.
Exclusion Criteria:
Other group exercise modalities or other forms of coordinated exercise (other than MSP) do not have a quality representative on their team and will not be considered for inclusion.
Characteristics of MSPs not included in the research:
- Where the members of the research team work.
Characteristics of professionals working in MSPs included:
- Not included.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Learning system benefits MSPs
MSPs benefit from a learning system (described in the intervention section).
MSPs are encouraged to report PSIs through the web platform provided after the initial training in each MSP and during the period of methodological support.
|
MSPs benefit from a learning system.
The learning system combines an individualised support programme provided by a regional support structure for quality and safety in health care (QualiREL Santé) and the provision of a web platform.
Based on the 4 dimensions of the Shortell model, the support programme includes initial training (6 months) and personalised methodological support (18 months) for each MSP.
A web platform is provided to MSPs to enable them to implement the full approach of the Risk Management Support Programme.
It provides support for reporting, analysis and management of PSIs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 1-by type
Time Frame: PSIs reported by MSP professionals in the 18 months following the initial training provided
|
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by type: the number of PSIs for each type out of the total number of PSIs reported.
|
PSIs reported by MSP professionals in the 18 months following the initial training provided
|
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 2- by contributing factors
Time Frame: 18 months
|
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by contributing factors : number of PSIs for each contributing factor (e.g.
factors related to the patient, staff, equipment, organisation, etc.) out of the total number of PSIs reported.
|
18 months
|
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 3-by results
Time Frame: 18 months
|
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by results: number of PSIs for each result (no harm, clinical harm, team harm) out of the total number of PSIs reported.
|
18 months
|
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 4-by severity
Time Frame: 18 months
|
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by severity: number of PSIs of each severity (e.g.
no harm, mild, moderate or severe harm, death) out of the total number of PSIs reported.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Description of MSP professionals' acceptance of learning system
Time Frame: 3 months
|
Analysis of the main themes and sub-themes of the acceptability of the learning system from the semi-directed interviews and focus groups conducted with MSP professionals.
|
3 months
|
Description of the behaviour of users of the online system in the 18 months following the provision of initial training
Time Frame: 18 months
|
Export from the web platform of
|
18 months
|
Description of the MSP's behaviour in implementing the risk management support programme during the 18 months following the provision of the initial training.
Time Frame: 18 months
|
Description: Export from the web platform of
|
18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RC23_0402
- RSP22N005 (Other Grant/Funding Number: French Ministry of Health: Direction générale offre de soins)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adverse Event
-
Xuanwu Hospital, BeijingUnknown
-
Université du Québec à Trois-RivièresCompleted
-
Hospices Civils de LyonUnknown
-
Universidad Miguel Hernandez de ElcheFundación para el Fomento de la Investigación Sanitaria y Biomédica de la...Active, not recruiting
-
Lucie HeinzerlingRecruitingImmune-related Adverse EventGermany
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanRecruitingImmune-related Adverse EventTaiwan
-
University of RochesterAgency for Healthcare Research and Quality (AHRQ)CompletedAdverse Drug Event, Potential Adverse Drug Event, and Quality MeasuresUnited States
-
Duke UniversityEnrolling by invitationCancer | Immune-related Adverse EventUnited States
-
Helse Stavanger HFCompletedRestenosis or Adverse Cardiovascular EventNorway
-
Universitair Ziekenhuis BrusselRecruitingDietary Habits | Immune-related Adverse EventBelgium
Clinical Trials on Health Services Research
-
Mayo ClinicCompletedRadiation DermatitisUnited States
-
University of CalgaryUniversity of Manitoba; McGill University; University of Alberta; McMaster University and other collaboratorsRecruitingMental Disorders | Mental Health | Pediatrics | Emergency PsychiatricCanada
-
University of Vermont Medical CenterRecruiting
-
VA Office of Research and DevelopmentCompletedTransplantUnited States
-
Virginia Commonwealth UniversityTerminated
-
University of Illinois at ChicagoNational Institute of Dental and Craniofacial Research (NIDCR)CompletedDental Caries in Children | Health Behavior | Healthcare DisparitiesUnited States
-
University of MichiganCenters for Disease Control and PreventionCompleted
-
Norwegian Board of Health SupervisionNorwegian Institute of Public Health; University of BergenCompleted
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingHIV Pre-Exposure ProphylaxisUnited States
-
Columbia UniversityBill and Melinda Gates Foundation; United NationsCompletedChild SurvivalEthiopia, Ghana, Kenya, Malawi, Mali, Nigeria, Rwanda, Senegal, Tanzania, Uganda